Kultgen; Steven G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kultgen; Steven G..The latest application filed is for "substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors".

Company Profile

7.12.15

Kultgen; Steven G. - Hamilton NJ
Kultgen; Steven G. - Salt Lake City UT
Kultgen; Steven G. - Dayton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Non-systemic TGR5 agonists Grant 11,236,055 - Huang , et al. February 1, 2	2022-02-01
Substituted Imidazo[1,2-b]pyridazines As Protein Kinase Inhibitors App 20210238183 - Xu; Yong ; et al.	2021-08-05
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors Grant 10,875,864 - Xu , et al. December 29, 2	2020-12-29
Novel Non-systemic Tgr5 Agonists App 20200308122 - Huang; Chia-Yu ; et al.	2020-10-01
Non-systemic TGR5 agonists Grant 10,654,834 - Huang , et al.	2020-05-19
Substituted Imidazo[1,2-b]pyridazines As Protein Kinase Inhibitors App 20200102313 - Xu; Yong ; et al.	2020-04-02
Novel Non-systemic Tgr5 Agonists App 20190330191 - Huang; Chia-Yu ; et al.	2019-10-31
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors Grant 10,392,392 - Xu , et al. A	2019-08-27
Substituted Imidazo[1,2-b]pyridazines As Protein Kinase Inhibitors App 20190071446 - Xu; Yong ; et al.	2019-03-07
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors Grant 10,047,093 - Xu , et al. August 14, 2	2018-08-14
Substituted Imidazo[1,2-b]pyridazines As Protein Kinase Inhibitors App 20170002014 - Xu; Yong ; et al.	2017-01-05
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors Grant 9,416,132 - Xu , et al. August 16, 2	2016-08-16
Heterocyclic Protein Kinase Inhibitors App 20140329807 - Xu; Yong ; et al.	2014-11-06
5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators Grant 8,211,927 - Roughton , et al. July 3, 2	2012-07-03
Isoxazole-5-carboxamide Derivatives App 20120071481 - Palin; Ronald ; et al.	2012-03-22
Imidazo[1,2-b]pyridazine And Pyrazolo[1,5-a]pyrimidine Derivatives And Their Use As Protein Kinase Inhibitors App 20120058997 - Xu; Yong ; et al.	2012-03-08
Compounds with medicinal effects due to interaction with the glucocorticoid receptor Grant 7,960,365 - Hamilton , et al. June 14, 2	2011-06-14
5- Phenyl-isoxazole-3-carboxamide Derivatives As Trpv1 Modulators App 20110065764 - Roughton; Andrew Laird ; et al.	2011-03-17
Compounds with medicinal effects due to interaction with the glucocorticoid receptor App 20070149577 - Hamilton; Niall Morton ; et al.	2007-06-28
2-(aminomethyl) arylamide analgesics Grant 7,084,154 - Ho , et al. August 1, 2	2006-08-01
Pyrimidine derivatives as IL-8 receptor antagonists Grant 7,037,916 - Erickson , et al. May 2, 2	2006-05-02
Bisaryl derivatives having FSH modulatory activity Grant 6,900,213 - Guo , et al. May 31, 2	2005-05-31
2-(aminomethyl) arylamide analgesics App 20040167119 - Ho, Koc-Kan ; et al.	2004-08-26
Bisaryl derivatives having FSH modulatory activity App 20040152703 - Guo, Tao ; et al.	2004-08-05
Pyrimidine derivatives as IL-8 receptor antagonists App 20040087601 - Erickson, Shawn David ; et al.	2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.